STRIVE
"STRIVE" is a word mark owned by Embecta Corp., filed at the USPTO on July 18, 2023. It has been allowed and covers classes 9 and 42.
- Status
- Allowed
- Since July 21, 2026
- Filed
- July 18, 2023
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 98090425
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns STRIVE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Embecta Corp.
EMBC · Parsippany, United States
Representative
Stephen R. Baird
Greenberg Traurig, LLP
What the mark covers
The products and services STRIVE is filed for, grouped by Nice class.
Downloadable computer software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Downloadable computer software for controlling and managing patient medical information; Downloadable computer software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Downloadable computer software for acquiring, analyzing, transmitting and storing medical and physiological data; Downloadable computer software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Downloadable computer software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Downloadable computer software for use in the treatment and management of diabetes; Downloadable computer software for linking medical instruments and devices for use in the treatment and management of diabetes; Downloadable computer software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Downloadable computer software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Downloadable computer software for monitoring blood glucose in connection with blood glucose monitors; Downloadable computer software for controlling insulin delivery in connection with insulin pumps; Downloadable computer software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Downloadable computer software for obtaining, controlling, and managing patient medical information on wearable medical devices; Downloadable computer software for controlling and managing wearable insulin delivery devices; Downloadable computer software used to display, manage, and monitor diabetes management information; Downloadable software in the nature of a mobile application for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Downloadable software in the nature of a mobile application for controlling and managing patient medical information; Downloadable software in the nature of a mobile application for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Downloadable software in the nature of a mobile application for acquiring, analyzing, transmitting and storing medical and physiological data; Downloadable software in the nature of a mobile application for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Downloadable software in the nature of a mobile application for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Downloadable software in the nature of a mobile application for use in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for linking medical instruments and devices for use in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Downloadable software in the nature of a mobile application for monitoring blood glucose in connection with blood glucose monitors; Downloadable software in the nature of a mobile application for controlling insulin delivery in connection with insulin pumps; Downloadable software in the nature of a mobile application for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Downloadable software in the nature of a mobile application for obtaining, controlling, and managing patient medical information on wearable medical devices; Downloadable software in the nature of a mobile application for controlling and managing wearable insulin delivery devices; Downloadable software in the nature of a mobile application used to display, manage, and monitor diabetes management information; Downloadable application programming interface (API) software; Wireless remote controllers for controlling and managing wearable insulin delivery devices
Providing temporary use of non-downloadable cloud-based software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Providing temporary use of non-downloadable cloud-based software for controlling and managing patient medical information; Providing temporary use of non-downloadable cloud-based software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Providing temporary use of non-downloadable cloud-based software for acquiring, analyzing, transmitting and storing medical and physiological data; Providing temporary use of non-downloadable cloud-based software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Providing temporary use of non-downloadable cloud-based software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Providing temporary use of non-downloadable cloud-based software for use in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for linking medical instruments and devices for use in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Providing temporary use of non-downloadable cloud-based software for monitoring blood glucose in connection with blood glucose monitors; Providing temporary use of non-downloadable cloud-based software for controlling insulin delivery in connection with insulin pumps; Providing temporary use of non-downloadable cloud-based software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Providing temporary use of non-downloadable cloud-based software for obtaining, controlling, and managing patient medical information on wearable medical devices; Providing temporary use of non-downloadable cloud-based software for controlling and managing wearable insulin delivery devices; Providing temporary use of non-downloadable cloud-based software used to display, manage, and monitor diabetes management information; Software as a Service (SAAS) services featuring software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Software as a Service (SAAS) services featuring software for controlling and managing patient medical information; Software as a Service (SAAS) services featuring software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Software as a Service (SAAS) services featuring software for acquiring, analyzing, transmitting and storing medical and physiological data; Software as a Service (SAAS) services featuring software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Software as a Service (SAAS) services featuring software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Software as a Service (SAAS) services featuring software for use in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for linking medical instruments and devices for use in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Software as a Service (SAAS) services featuring software for monitoring blood glucose in connection with blood glucose monitors; Software as a Service (SAAS) services featuring software for controlling insulin delivery in connection with insulin pumps; Software as a Service (SAAS) services featuring software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Software as a Service (SAAS) services featuring software for obtaining, controlling, and managing patient medical information on wearable medical devices; Software as a Service (SAAS) services featuring software for controlling and managing wearable insulin delivery devices; Software as a Service (SAAS) services featuring software used to display, manage, and monitor diabetes management information; Application service provider (ASP) featuring software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Application service provider (ASP) featuring software for controlling and managing patient medical information; Application service provider (ASP) featuring software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Application service provider (ASP) featuring software for acquiring, analyzing, transmitting and storing medical and physiological data; Application service provider (ASP) featuring software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Application service provider (ASP) featuring software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Application service provider (ASP) featuring software for use in the treatment and management of diabetes; Application service provider (ASP) featuring software for linking medical instruments and devices for use in the treatment and management of diabetes; Application service provider (ASP) featuring software for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Application service provider (ASP) featuring software for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Application service provider (ASP) featuring software for monitoring blood glucose in connection with blood glucose monitors; Application service provider (ASP) featuring software for controlling insulin delivery in connection with insulin pumps; Application service provider (ASP) featuring software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Application service provider (ASP) featuring software for obtaining, controlling, and managing patient medical information on wearable medical devices; Application service provider (ASP) featuring software for controlling and managing wearable insulin delivery devices; Application service provider (ASP) featuring software for used to display, manage, and monitor diabetes management information; Application service provider featuring application programming interface (API) software; Consultation services relating to computer software; Providing on-line non-downloadable software featuring patient information management tools in the field of diabetes
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Suspension checked - to attorney for action
- Notification of letter of suspension e-mailed
- Letter of suspension e-mailed
- Suspension letter written
- Teas/email correspondence entered
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About STRIVE
Who owns the trademark "STRIVE"?
The USPTO trademark "STRIVE" (application 98090425) is owned by Embecta Corp.
What is the status of "STRIVE"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull STRIVE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2be9-d1d2-7263-b6d9-bbe0ce22cb3c
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2be9-d1d2-7263-b6d9-bbe0ce22cb3c",
"object": "trademark",
"mark_text": "STRIVE",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "98090425",
"filing_date": "2023-07-18",
"nice_classes": [
9,
42
],
"owners": [
{
"name": "Embecta Corp.",
"entity_id": "ent_019f286b-e289-72ae-8107-4fda2e6cb481"
}
]
}